Supernus Pharmaceuticals, Inc.
Clinical trials sponsored by Supernus Pharmaceuticals, Inc., explained in plain language.
-
Huntington's drug safety trial ends early
Disease control TerminatedThis study looked at the long-term safety of an experimental drug called SAGE-718 for people with Huntington's disease. The trial planned to enroll 153 participants and was in Phase 3, but it was terminated early. The main goal was to track side effects and other safety measures,…
Phase: PHASE3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 04:40 UTC
-
Migraine prevention drug for kids falls short in early trial
Prevention TerminatedThis study tested whether the drug SPN-538 could prevent migraines in children aged 6 to 11. Researchers planned to compare the number of migraine days in children taking the drug versus a placebo. The study was stopped early and only included 26 participants, so results are limi…
Phase: PHASE4 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Prevention
Last updated May 26, 2026 04:32 UTC